Bookman Michael 4
4 · Immuneering Corp · Filed Feb 14, 2022
Insider Transaction Report
Form 4
Immuneering CorpIMRX
Bookman Michael
CHIEF LEGAL OFFICER, SECRETARY
Transactions
- Award
Stock Option
2022-02-10+47,300→ 47,300 totalExercise: $9.66Exp: 2032-02-09→ Class A Common Stock (47,300 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2022, and will be fully vested and exercisable on January 1, 2026.